Oncology Precision Medicine Market - Global Outlook and Forecast 2021-2027

March 2021 | 112 pages | ID: OC39A62BF949EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Oncology Precision Medicine in Global, including the following market information:

Global Oncology Precision Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Oncology Precision Medicine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Precision Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncology Precision Medicine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Oncology Precision Medicine Market Segment Percentages, By Type, 2020 (%)

• Applied Sciences
• Precision Diagnostics
• Digital Health and Information Technology
• Precision Therapeutics

China Oncology Precision Medicine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Oncology Precision Medicine Market Segment Percentages, By Application, 2020 (%)

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• Other Cancer

Global Oncology Precision Medicine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Oncology Precision Medicine Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Oncology Precision Medicine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Oncology Precision Medicine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Abbott Laboratories
• Agilent Technologies
• Almac
• ANGLE plc
• Asuragen
• BGI Group
• Bio-Rad Laboratories
• BioM?rieux
• Bristol Myers Squibb
• Roche Holding AG
• Gilead Sciences
• Illumina
• Konica Minolta
• LabCorp
• MDxHealth
• Myriad Genetics
• Novartis
• OPKO Health
• Pacific Biosciences
• Quest Diagnostics
• Qiagen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oncology Precision Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oncology Precision Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ONCOLOGY PRECISION MEDICINE OVERALL MARKET SIZE

2.1 Global Oncology Precision Medicine Market Size: 2021 VS 2027
2.2 Global Oncology Precision Medicine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oncology Precision Medicine Players in Global Market
3.2 Top Global Oncology Precision Medicine Companies Ranked by Revenue
3.3 Global Oncology Precision Medicine Revenue by Companies
3.4 Top 3 and Top 5 Oncology Precision Medicine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oncology Precision Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Precision Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Oncology Precision Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oncology Precision Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Oncology Precision Medicine Market Size Markets, 2021 & 2027
  4.1.2 Applied Sciences
  4.1.3 Precision Diagnostics
  4.1.4 Digital Health and Information Technology
  4.1.5 Precision Therapeutics
4.2 By Type - Global Oncology Precision Medicine Revenue & Forecasts
  4.2.1 By Type - Global Oncology Precision Medicine Revenue, 2016-2021
  4.2.2 By Type - Global Oncology Precision Medicine Revenue, 2022-2027
  4.2.3 By Type - Global Oncology Precision Medicine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oncology Precision Medicine Market Size, 2021 & 2027
  5.1.2 Breast Cancer
  5.1.3 Lung Cancer
  5.1.4 Colorectal Cancer
  5.1.5 Prostate Cancer
  5.1.6 Cervical Cancer
  5.1.7 Other Cancer
5.2 By Application - Global Oncology Precision Medicine Revenue & Forecasts
  5.2.1 By Application - Global Oncology Precision Medicine Revenue, 2016-2021
  5.2.2 By Application - Global Oncology Precision Medicine Revenue, 2022-2027
  5.2.3 By Application - Global Oncology Precision Medicine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Oncology Precision Medicine Market Size, 2021 & 2027
6.2 By Region - Global Oncology Precision Medicine Revenue & Forecasts
  6.2.1 By Region - Global Oncology Precision Medicine Revenue, 2016-2021
  6.2.2 By Region - Global Oncology Precision Medicine Revenue, 2022-2027
  6.2.3 By Region - Global Oncology Precision Medicine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Oncology Precision Medicine Revenue, 2016-2027
  6.3.2 US Oncology Precision Medicine Market Size, 2016-2027
  6.3.3 Canada Oncology Precision Medicine Market Size, 2016-2027
  6.3.4 Mexico Oncology Precision Medicine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Oncology Precision Medicine Revenue, 2016-2027
  6.4.2 Germany Oncology Precision Medicine Market Size, 2016-2027
  6.4.3 France Oncology Precision Medicine Market Size, 2016-2027
  6.4.4 U.K. Oncology Precision Medicine Market Size, 2016-2027
  6.4.5 Italy Oncology Precision Medicine Market Size, 2016-2027
  6.4.6 Russia Oncology Precision Medicine Market Size, 2016-2027
  6.4.7 Nordic Countries Oncology Precision Medicine Market Size, 2016-2027
  6.4.8 Benelux Oncology Precision Medicine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Oncology Precision Medicine Revenue, 2016-2027
  6.5.2 China Oncology Precision Medicine Market Size, 2016-2027
  6.5.3 Japan Oncology Precision Medicine Market Size, 2016-2027
  6.5.4 South Korea Oncology Precision Medicine Market Size, 2016-2027
  6.5.5 Southeast Asia Oncology Precision Medicine Market Size, 2016-2027
  6.5.6 India Oncology Precision Medicine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Oncology Precision Medicine Revenue, 2016-2027
  6.6.2 Brazil Oncology Precision Medicine Market Size, 2016-2027
  6.6.3 Argentina Oncology Precision Medicine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oncology Precision Medicine Revenue, 2016-2027
  6.7.2 Turkey Oncology Precision Medicine Market Size, 2016-2027
  6.7.3 Israel Oncology Precision Medicine Market Size, 2016-2027
  6.7.4 Saudi Arabia Oncology Precision Medicine Market Size, 2016-2027
  6.7.5 UAE Oncology Precision Medicine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Oncology Precision Medicine Major Product Offerings
  7.1.4 Abbott Laboratories Oncology Precision Medicine Revenue in Global (2016-2021)
  7.1.5 Abbott Laboratories Key News
7.2 Agilent Technologies
  7.2.1 Agilent Technologies Corporate Summary
  7.2.2 Agilent Technologies Business Overview
  7.2.3 Agilent Technologies Oncology Precision Medicine Major Product Offerings
  7.2.4 Agilent Technologies Oncology Precision Medicine Revenue in Global (2016-2021)
  7.2.5 Agilent Technologies Key News
7.3 Almac
  7.3.1 Almac Corporate Summary
  7.3.2 Almac Business Overview
  7.3.3 Almac Oncology Precision Medicine Major Product Offerings
  7.3.4 Almac Oncology Precision Medicine Revenue in Global (2016-2021)
  7.3.5 Almac Key News
7.4 ANGLE plc
  7.4.1 ANGLE plc Corporate Summary
  7.4.2 ANGLE plc Business Overview
  7.4.3 ANGLE plc Oncology Precision Medicine Major Product Offerings
  7.4.4 ANGLE plc Oncology Precision Medicine Revenue in Global (2016-2021)
  7.4.5 ANGLE plc Key News
7.5 Asuragen
  7.5.1 Asuragen Corporate Summary
  7.5.2 Asuragen Business Overview
  7.5.3 Asuragen Oncology Precision Medicine Major Product Offerings
  7.5.4 Asuragen Oncology Precision Medicine Revenue in Global (2016-2021)
  7.5.5 Asuragen Key News
7.6 BGI Group
  7.6.1 BGI Group Corporate Summary
  7.6.2 BGI Group Business Overview
  7.6.3 BGI Group Oncology Precision Medicine Major Product Offerings
  7.6.4 BGI Group Oncology Precision Medicine Revenue in Global (2016-2021)
  7.6.5 BGI Group Key News
7.7 Bio-Rad Laboratories
  7.7.1 Bio-Rad Laboratories Corporate Summary
  7.7.2 Bio-Rad Laboratories Business Overview
  7.7.3 Bio-Rad Laboratories Oncology Precision Medicine Major Product Offerings
  7.4.4 Bio-Rad Laboratories Oncology Precision Medicine Revenue in Global (2016-2021)
  7.7.5 Bio-Rad Laboratories Key News
7.8 BioM?rieux
  7.8.1 BioM?rieux Corporate Summary
  7.8.2 BioM?rieux Business Overview
  7.8.3 BioM?rieux Oncology Precision Medicine Major Product Offerings
  7.8.4 BioM?rieux Oncology Precision Medicine Revenue in Global (2016-2021)
  7.8.5 BioM?rieux Key News
7.9 Bristol Myers Squibb
  7.9.1 Bristol Myers Squibb Corporate Summary
  7.9.2 Bristol Myers Squibb Business Overview
  7.9.3 Bristol Myers Squibb Oncology Precision Medicine Major Product Offerings
  7.9.4 Bristol Myers Squibb Oncology Precision Medicine Revenue in Global (2016-2021)
  7.9.5 Bristol Myers Squibb Key News
7.10 Roche Holding AG
  7.10.1 Roche Holding AG Corporate Summary
  7.10.2 Roche Holding AG Business Overview
  7.10.3 Roche Holding AG Oncology Precision Medicine Major Product Offerings
  7.10.4 Roche Holding AG Oncology Precision Medicine Revenue in Global (2016-2021)
  7.10.5 Roche Holding AG Key News
7.11 Gilead Sciences
  7.11.1 Gilead Sciences Corporate Summary
  7.11.2 Gilead Sciences Business Overview
  7.11.3 Gilead Sciences Oncology Precision Medicine Major Product Offerings
  7.11.4 Gilead Sciences Oncology Precision Medicine Revenue in Global (2016-2021)
  7.11.5 Gilead Sciences Key News
7.12 Illumina
  7.12.1 Illumina Corporate Summary
  7.12.2 Illumina Business Overview
  7.12.3 Illumina Oncology Precision Medicine Major Product Offerings
  7.12.4 Illumina Oncology Precision Medicine Revenue in Global (2016-2021)
  7.12.5 Illumina Key News
7.13 Konica Minolta
  7.13.1 Konica Minolta Corporate Summary
  7.13.2 Konica Minolta Business Overview
  7.13.3 Konica Minolta Oncology Precision Medicine Major Product Offerings
  7.13.4 Konica Minolta Oncology Precision Medicine Revenue in Global (2016-2021)
  7.13.5 Konica Minolta Key News
7.14 LabCorp
  7.14.1 LabCorp Corporate Summary
  7.14.2 LabCorp Business Overview
  7.14.3 LabCorp Oncology Precision Medicine Major Product Offerings
  7.14.4 LabCorp Oncology Precision Medicine Revenue in Global (2016-2021)
  7.14.5 LabCorp Key News
7.15 MDxHealth
  7.15.1 MDxHealth Corporate Summary
  7.15.2 MDxHealth Business Overview
  7.15.3 MDxHealth Oncology Precision Medicine Major Product Offerings
  7.15.4 MDxHealth Oncology Precision Medicine Revenue in Global (2016-2021)
  7.15.5 MDxHealth Key News
7.16 Myriad Genetics
  7.16.1 Myriad Genetics Corporate Summary
  7.16.2 Myriad Genetics Business Overview
  7.16.3 Myriad Genetics Oncology Precision Medicine Major Product Offerings
  7.16.4 Myriad Genetics Oncology Precision Medicine Revenue in Global (2016-2021)
  7.16.5 Myriad Genetics Key News
7.17 Novartis
  7.17.1 Novartis Corporate Summary
  7.17.2 Novartis Business Overview
  7.17.3 Novartis Oncology Precision Medicine Major Product Offerings
  7.17.4 Novartis Oncology Precision Medicine Revenue in Global (2016-2021)
  7.17.5 Novartis Key News
7.18 OPKO Health
  7.18.1 OPKO Health Corporate Summary
  7.18.2 OPKO Health Business Overview
  7.18.3 OPKO Health Oncology Precision Medicine Major Product Offerings
  7.18.4 OPKO Health Oncology Precision Medicine Revenue in Global (2016-2021)
  7.18.5 OPKO Health Key News
7.19 Pacific Biosciences
  7.19.1 Pacific Biosciences Corporate Summary
  7.19.2 Pacific Biosciences Business Overview
  7.19.3 Pacific Biosciences Oncology Precision Medicine Major Product Offerings
  7.19.4 Pacific Biosciences Oncology Precision Medicine Revenue in Global (2016-2021)
  7.19.5 Pacific Biosciences Key News
7.20 Quest Diagnostics
  7.20.1 Quest Diagnostics Corporate Summary
  7.20.2 Quest Diagnostics Business Overview
  7.20.3 Quest Diagnostics Oncology Precision Medicine Major Product Offerings
  7.20.4 Quest Diagnostics Oncology Precision Medicine Revenue in Global (2016-2021)
  7.20.5 Quest Diagnostics Key News
7.21 Qiagen
  7.21.1 Qiagen Corporate Summary
  7.21.2 Qiagen Business Overview
  7.21.3 Qiagen Oncology Precision Medicine Major Product Offerings
  7.21.4 Qiagen Oncology Precision Medicine Revenue in Global (2016-2021)
  7.21.5 Qiagen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oncology Precision Medicine Market Opportunities & Trends in Global Market
Table 2. Oncology Precision Medicine Market Drivers in Global Market
Table 3. Oncology Precision Medicine Market Restraints in Global Market
Table 4. Key Players of Oncology Precision Medicine in Global Market
Table 5. Top Oncology Precision Medicine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oncology Precision Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oncology Precision Medicine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oncology Precision Medicine Product Type
Table 9. List of Global Tier 1 Oncology Precision Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Precision Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Oncology Precision Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Oncology Precision Medicine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Oncology Precision Medicine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Oncology Precision Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Oncology Precision Medicine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Oncology Precision Medicine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Oncology Precision Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Oncology Precision Medicine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Oncology Precision Medicine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Oncology Precision Medicine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Oncology Precision Medicine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Oncology Precision Medicine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Oncology Precision Medicine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Oncology Precision Medicine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Oncology Precision Medicine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Oncology Precision Medicine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Oncology Precision Medicine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Oncology Precision Medicine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Oncology Precision Medicine Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Oncology Precision Medicine Product Offerings
Table 32. Abbott Laboratories Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 33. Agilent Technologies Corporate Summary
Table 34. Agilent Technologies Oncology Precision Medicine Product Offerings
Table 35. Agilent Technologies Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 36. Almac Corporate Summary
Table 37. Almac Oncology Precision Medicine Product Offerings
Table 38. Almac Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 39. ANGLE plc Corporate Summary
Table 40. ANGLE plc Oncology Precision Medicine Product Offerings
Table 41. ANGLE plc Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 42. Asuragen Corporate Summary
Table 43. Asuragen Oncology Precision Medicine Product Offerings
Table 44. Asuragen Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 45. BGI Group Corporate Summary
Table 46. BGI Group Oncology Precision Medicine Product Offerings
Table 47. BGI Group Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 48. Bio-Rad Laboratories Corporate Summary
Table 49. Bio-Rad Laboratories Oncology Precision Medicine Product Offerings
Table 50. Bio-Rad Laboratories Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 51. BioM?rieux Corporate Summary
Table 52. BioM?rieux Oncology Precision Medicine Product Offerings
Table 53. BioM?rieux Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 54. Bristol Myers Squibb Corporate Summary
Table 55. Bristol Myers Squibb Oncology Precision Medicine Product Offerings
Table 56. Bristol Myers Squibb Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 57. Roche Holding AG Corporate Summary
Table 58. Roche Holding AG Oncology Precision Medicine Product Offerings
Table 59. Roche Holding AG Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 60. Gilead Sciences Corporate Summary
Table 61. Gilead Sciences Oncology Precision Medicine Product Offerings
Table 62. Gilead Sciences Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 63. Illumina Corporate Summary
Table 64. Illumina Oncology Precision Medicine Product Offerings
Table 65. Illumina Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 66. Konica Minolta Corporate Summary
Table 67. Konica Minolta Oncology Precision Medicine Product Offerings
Table 68. Konica Minolta Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 69. LabCorp Corporate Summary
Table 70. LabCorp Oncology Precision Medicine Product Offerings
Table 71. LabCorp Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 72. MDxHealth Corporate Summary
Table 73. MDxHealth Oncology Precision Medicine Product Offerings
Table 74. MDxHealth Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 75. Myriad Genetics Corporate Summary
Table 76. Myriad Genetics Oncology Precision Medicine Product Offerings
Table 77. Myriad Genetics Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 78. Novartis Corporate Summary
Table 79. Novartis Oncology Precision Medicine Product Offerings
Table 80. Novartis Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 81. OPKO Health Corporate Summary
Table 82. OPKO Health Oncology Precision Medicine Product Offerings
Table 83. OPKO Health Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 84. Pacific Biosciences Corporate Summary
Table 85. Pacific Biosciences Oncology Precision Medicine Product Offerings
Table 86. Pacific Biosciences Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 87. Quest Diagnostics Corporate Summary
Table 88. Quest Diagnostics Oncology Precision Medicine Product Offerings
Table 89. Quest Diagnostics Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)
Table 90. Qiagen Corporate Summary
Table 91. Qiagen Oncology Precision Medicine Product Offerings
Table 92. Qiagen Oncology Precision Medicine Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Precision Medicine Segment by Type
Figure 2. Oncology Precision Medicine Segment by Application
Figure 3. Global Oncology Precision Medicine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oncology Precision Medicine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oncology Precision Medicine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Precision Medicine Revenue in 2020
Figure 8. By Type - Global Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 9. By Application - Global Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 10. By Region - Global Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 11. By Country - North America Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 12. US Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 16. Germany Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 17. France Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 24. China Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 28. India Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 30. Brazil Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Oncology Precision Medicine Revenue Market Share, 2016-2027
Figure 33. Turkey Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Oncology Precision Medicine Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Laboratories Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Agilent Technologies Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Almac Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. ANGLE plc Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Asuragen Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. BGI Group Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Bio-Rad Laboratories Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. BioM?rieux Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bristol Myers Squibb Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Roche Holding AG Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Gilead Sciences Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Illumina Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Konica Minolta Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. LabCorp Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. MDxHealth Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Myriad Genetics Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Novartis Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. OPKO Health Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Pacific Biosciences Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Quest Diagnostics Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Qiagen Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)